HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Eidelberg Selected Research

4- phenyl- 5,5- dicarbethoxy- 2- pyrrolidinone

1/2022Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer's disease topography.
10/2021Cognition-Related Functional Topographies in Parkinson's Disease: Localized Loss of the Ventral Default Mode Network.
3/2021Dynamic 18F-FPCIT PET: Quantification of Parkinson's disease metabolic networks and nigrostriatal dopaminergic dysfunction in a single imaging session.
11/2016Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
9/2015Abnormal metabolic pattern associated with cognitive impairment in Parkinson's disease: a validation study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Eidelberg Research Topics

Disease

53Parkinson Disease (Parkinson's Disease)
06/2022 - 08/2002
13Parkinsonian Disorders (Parkinsonism)
04/2021 - 11/2002
12Neurodegenerative Diseases (Neurodegenerative Disease)
11/2022 - 07/2003
10Dyskinesias (Dyskinesia)
06/2021 - 11/2002
9Alzheimer Disease (Alzheimer's Disease)
11/2022 - 02/2009
8Cognitive Dysfunction
10/2021 - 08/2009
7Dementia (Dementias)
11/2022 - 08/2009
7Disease Progression
01/2017 - 07/2007
5Huntington Disease (Huntington's Disease)
09/2013 - 07/2007
4Multiple System Atrophy
02/2017 - 11/2002
4Tremor (Tremors)
12/2016 - 02/2004
4Movement Disorders (Movement Disorder)
10/2016 - 04/2005
4Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2015 - 01/2011
3Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2018 - 01/2009
3Neurobehavioral Manifestations
10/2011 - 04/2007
2REM Sleep Behavior Disorder
12/2015 - 11/2015
2Dystonia (Limb Dystonia)
01/2015 - 07/2003
2Dystonia musculorum deformans type 1
01/2015 - 07/2003
1Hypokinesia (Bradykinesia)
04/2021
1Frontotemporal Dementia (Semantic Dementia)
01/2018
1Corticobasal Degeneration
02/2017
1Traumatic Brain Injuries (Traumatic Brain Injury)
06/2015
1Brain Diseases (Brain Disorder)
08/2014
1Inflammation (Inflammations)
08/2014
1Type 2 Diabetes Mellitus (MODY)
04/2014
1Mental Disorders (Mental Disorder)
11/2012
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
10/2012
1Secondary Parkinson Disease (Secondary Parkinsonism)
04/2012
1Basal Ganglia Diseases (Basal Ganglia Disease)
05/2011
1Vascular Diseases (Vascular Disease)
01/2011
1Essential Tremor (Essential Tremors)
04/2010
1Atrophy
08/2009
1Mood Disorders (Mood Disorder)
08/2009
1Marijuana Abuse (Cannabis Abuse)
05/2008
1Dopa-responsive Dystonia
04/2005
1Neoplasms (Cancer)
03/2003

Drug/Important Bio-Agent (IBA)

23Biomarkers (Surrogate Marker)IBA
11/2022 - 07/2007
16Levodopa (L Dopa)FDA LinkGeneric
06/2021 - 03/2003
14Glucose (Dextrose)FDA LinkGeneric
01/2019 - 07/2003
9Dopamine (Intropin)FDA LinkGeneric
04/2021 - 11/2002
6Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2021 - 01/2015
5Pharmaceutical PreparationsIBA
06/2022 - 08/2015
54- phenyl- 5,5- dicarbethoxy- 2- pyrrolidinoneIBA
01/2022 - 09/2015
4Serotonin (5 Hydroxytryptamine)IBA
11/2012 - 02/2004
3AntibodiesIBA
01/2019 - 01/2011
2Amyloid (Amyloid Fibrils)IBA
01/2020 - 10/2012
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2019 - 06/2015
2Oxidopamine (6 Hydroxydopamine)IBA
11/2017 - 12/2016
2Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
02/2017 - 04/2010
2salicylhydroxamic acid (SHAM)IBA
01/2017 - 08/2014
2Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
01/2017 - 06/2007
2Cholinergic Agents (Cholinergics)IBA
10/2012 - 02/2009
2Antidepressive Agents (Antidepressants)IBA
10/2011 - 12/2004
1Phenylalanine (L-Phenylalanine)FDA Link
06/2022
1NAD (NADH)IBA
01/2022
1nicotinamide-beta-ribosideIBA
01/2022
1alpha-Methyltyrosine (Metirosine)FDA Link
04/2021
1Amantadine (Aman)FDA LinkGeneric
04/2021
1Clozapine (Clozaril)FDA LinkGeneric
04/2021
1Cholinergic Antagonists (Anticholinergics)IBA
04/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2020
1N-Methylaspartate (NMDA)IBA
01/2019
1Fluorine-18IBA
01/2019
1Retinal Pigments (Pigments, Visual)IBA
10/2016
1AutoantibodiesIBA
01/2015
1Glutamic Acid (Glutamate)FDA Link
01/2015
1AcetylcholinesteraseIBA
10/2012
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
04/2012
1fluorodopa F 18IBA
01/2012
1thymidine 3',5'-diphosphate (pdTp)IBA
01/2011
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2011
1CytokinesIBA
01/2011
1technetium Tc 99m bicisate (Neurolite)FDA Link
04/2010
1Galantamine (Galanthamine)FDA LinkGeneric
02/2009
1CitalopramFDA LinkGeneric
02/2009
1RacloprideIBA
05/2008
1Cholinesterase Inhibitors (Anticholinesterases)IBA
04/2006
1ethyleneIBA
11/2002

Therapy/Procedure

22Therapeutics
01/2022 - 03/2003
8Deep Brain Stimulation
01/2021 - 08/2002
3Drug Therapy (Chemotherapy)
10/2016 - 03/2003
2Investigational Therapies (Experimental Therapy)
10/2016 - 12/2007
2Cell Transplantation
01/2011 - 11/2002
2Transplantation
01/2011 - 11/2002
1Fetal Tissue Transplantation
04/2021
1Tissue Transplantation
04/2021
1Electrodes (Electrode)
06/2009
1Aftercare (After-Treatment)
03/2003